Connect with us

Hi, what are you looking for?

Jewish Business News

Search results for "Copaxone"

Business

[FULL LETTER] After Mylan Responded aggressively to Teva's bid, Erez Vigodman says in an open letter to Robert Coury: Shareholders won't benefit from Mud...

Business

Board concludes that approach grossly undervalues Mylan, includes Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of...

Blogs

The body’s immune system can easily recognize its own cells

Money

Shares of Teva Pharmaceutical Industries traded up 0.87% on Monday, hitting $62.52.

Business

It's tictoc, tictoc, for Teva.

Business

Berenberg analysts see insurance companies pressuring MS patients to switch to generic versions of Copaxone. Last year, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE:...

Business

Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a...

Business

  Here is our list of the ten companies that made the biggest or at least the most headlines this past year, for good...

Business

– Relations between Teva and Biotec have deteriorated into a legal dispute and an entanglement with the Russian authorities. –   After years of...

StartUps

Israeli biomed firm Mapi Pharma Ltd., which is a development stage pharmaceutical company, announced that the first patient was treated in the company’s Phase...